Income Statement
COMPASS THERAPEUTICS, INC.
CMPX
Performance Overview
Click any row in the table to add it to this chart
in millions USD
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY | Dec 31, 2020 2020 FY | Mar 31, 2020 2019 FY | Mar 31, 2019 2018 FY |
|---|---|---|---|---|---|---|---|---|
|
Revenue
|
- | - | - | - | - | - | - | - |
|
Cost of Revenue
|
- | - | - | - | - | - | - | - |
|
Gross Profit
|
- | - | - | - | - | - | - | - |
|
Operating Expenses
|
72.84 | 57.48 | 50.36 | 41.66 | 81.88 | 27.81 | 0.03 | 0.03 |
|
Research & Development
|
55.97 | 42.34 | 38.12 | 30.00 | 20.34 | 14.90 | - | - |
|
Selling, General & Administrative
|
16.87 | 15.13 | 12.24 | 11.66 | 10.93 | 12.91 | 0.03 | 0.03 |
|
Other Operating Expenses
|
- | - | - | - | - | - | - | - |
|
Operating Income
|
-72.84 | -57.48 | -50.36 | -41.66 | -81.88 | -27.81 | -0.03 | -0.03 |
|
Non-Operating Income
|
- | - | -7.87 | -2.43 | 0.30 | -1.66 | - | - |
|
Interest Income
|
6.40 | 7.30 | 7.87 | 2.36 | 0.03 | 0.09 | - | - |
|
Interest Expense
|
- | - | - | 0.00 | 0.40 | 0.91 | 0.01 | 0.00 |
|
Other Non-Op Income / Expense
|
6.35 | 7.25 | 7.87 | 2.43 | -0.30 | -0.75 | - | - |
|
Income Before Tax
|
- | - | -42.49 | -39.23 | -82.18 | -29.47 | - | - |
|
Income Tax Expense
|
- | - | 0.00 | 0.00 | 0.00 | 0.03 | - | - |
|
Non-Controlling Interest
|
- | - | - | - | - | - | - | - |
|
Net Income
|
-66.49 | -49.38 | -42.49 | -39.23 | -82.18 | -29.50 | -0.04 | -0.04 |
Supplemental
Per share data, derived & other items — not part of the income statement
in millions USD unless noted
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY | Dec 31, 2020 2020 FY | Mar 31, 2020 2019 FY | Mar 31, 2019 2018 FY |
|---|---|---|---|---|---|---|---|---|
|
Depreciation & Amortization
|
- | - | - | - | - | - | - | - |
|
EBITDA
|
-72.56 | -56.89 | -49.66 | -40.87 | -81.32 | -25.41 | -0.03 | -0.03 |
|
Earnings Per Share (Basic)
|
-0.42 | -0.36 | -0.33 | -0.37 | - | - | - | - |
|
Diluted EPS
|
- | - | - | - | - | - | - | - |
|
Weighted Average Shares
|
157.70 | 137.38 | 127.03 | 105.19 | - | - | - | - |
|
Diluted Weighted Avg Shares
|
- | - | - | - | - | - | - | - |
|
Comprehensive Income
|
-66.42 | -49.20 | -42.16 | -39.53 | - | - | - | - |